跳至主要内容
临床试验/CTRI/2014/02/004375
CTRI/2014/02/004375已完成4 期

Efficacy and adverse reactions of single dose DEC of 100 mg, 200 mg and 300 mg strength in filariasis endemic community in Orissa

Regional Medical Research Centre ICMR0 个研究点目标入组 900 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
900

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • More than 5 years one site regimen consisting 100 mg DEC second site regimen consisting of 200 mg DEC and third site regimen consisting of 300 mg DEC annually oral single dose for 2 to 5 years child all sites given 100 mg DEC annually oral single dose

排除标准

  • More than 2 yrs, pregnant women, seriously ill subjects

研究者

发起方
Regional Medical Research Centre ICMR

相似试验